The effect of empagliflozin and fenofibrate therapies, alone and in combination, on the serum urate concentration in hyperuricaemic type 2 diabetes.
Timothy M E DavisSharon MaxwellCathy ChanHelen I KeenWendy A DavisPublished in: Diabetes, obesity & metabolism (2023)